Global RSV Diagnostics Market Size, Share, Forecast Report, 2020-2027

The global RSV diagnostics market is expected to gain prominence over the forecast period (2018–2023). It is estimated that the global RSV diagnostics market is expected to register a CAGR ~ 10.4 % during the forecast period of 2018–2023.

Human Respiratory Syncytial Virus (RSV) is a virus that commonly causes lower respiratory tract infection. RSV is a significant cause of severe respiratory illness in premature babies and children up to the age of five years. Its symptoms can range from a mild cold-like illness to bronchiolitis and pneumonia. Rising occurrence of respiratory infections, growing neonatal population base, rising demand for in-vitro diagnostics, and increasing demand for point of care facilities are the major factors driving the growth of the market. For instance, according to the World Health Organization (WHO), in 2015, pneumonia accounted for 16 % of all deaths of children below five years of age with 9, 20,136 children deaths.

Despite the drivers, factors such as lack of availability of specific treatment options and the high number of other pathogens that cause similar symptoms of respiratory illness may hinder the growth of the market.

Segmentation

The global RSV diagnostics market is segmented on the basis of the product, method, and end-user.

On the basis of product, the market is classified into kits and assays, instruments, and other products.

The global RSV diagnostics market on the basis of the method is segmented into molecular diagnostics, rapid antigen detection test, gel microdroplets, flow cytometry, and others. The rapid antigen detection tests are further classified into enzyme-linked immunosorbent assays, immunofluorescence assays, and other rapid antigen detection tests. The other rapid antigen detection tests are classified into chromatographic immunoassays and optical immunoassays.

On basis of end-user, the market is segmented into hospitals and clinics, clinical laboratories, home care, and others.Key Players

Quest Diagnostics, Biomerieux, Becton, Dickinson, and Company (BD), Abbott, F. Hoffman-La Roche Ltd., Danaher Corporation, Thermo Fisher Scientific, Biocartis, Luminex, Hologic, Fast Track Diagnostics, Bio-Rad Laboratories Inc., Alere, Inc., Quidel Corporation, others are some prominent players in this market.